Early Assessment by FDG-PET/CT of Patients with Advanced Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors is Predictive of Disease Course Full Text
BMC Cancer,

Ueno D et al. – The evaluation of renal cell carcinoma (RCC) response to tyrosine kinase inhibitors (TKIs) by tumor size and FDG uptake using 18F–2–fluoro–2–deoxyglucose positron emission tomography/ computed tomography (FDG PET/CT) after 1month can predict progression free survival (PFS) and overall survival (OS).

Please login or register to follow this author.
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Radiology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Radiology Articles

Indexed Journals in Radiology: Clinical Radiology, American Journal of Roengenology, Academic Radiologymore